Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5d1ac47a0b7cf0981654becfe992d9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5dd388a5130b0bdede0fdfc6c2af6ed |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55566 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74 |
filingDate |
2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45c8596bfa423b51b615c3f2d23614b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_315c40e7fd0fdea62d4ed88c14961d24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_361978c53c4844cfa1834bfbb0f40caf |
publicationDate |
2021-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-113164573-A |
titleOfInvention |
Recombinant polypeptides comprising modified MHC class II DR alpha1 domains and methods of use thereof |
abstract |
The present invention provides recombinant polypeptides comprising a modified DR α 1 domain. In some embodiments, the polypeptide comprises a modified DR α 1 domain, an antigenic peptide, and optionally a linker sequence. The invention also provides pharmaceutical compositions comprising the recombinant polypeptides, methods of treating inflammatory diseases using the recombinant polypeptides or pharmaceutical compositions, and expression constructs comprising nucleic acids encoding the recombinant polypeptides. |
priorityDate |
2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |